Aspiriant, LLC Moderna, Inc. Transaction History

Aspiriant, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$126.46 - $235.05 $315,138 - $585,744	-2,492 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $8,806 - $14,371	39 Added 1.59%	2,492 $632,000
Q3 2021 Oct 27, 2021	SELL	$221.9 - $484.47 $201,041 - $438,929	-906 Reduced 26.97%	2,453 $944,000
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $436,367 - $789,297	3,359 New	3,359 $789,000
Q4 2020 Feb 01, 2021	SELL	$65.74 - $169.86 $493,049 - $1.27 Million	-7,500 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $407,550 - $711,375	7,500 New	7,500 $531,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.